CoChat
Sign Up
Cited by 107

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles

Haraszti, Reka Agnes, Miller, Rachael, Didiot, Marie-Cecile, Biscans, Annabelle, Alterman, Julia F., Hassler, Matthew R., Roux, Loic, Echeverria, Dimas, Sapp, Ellen, DiFiglia, Marian, Aronin, Neil, Khvorova, Anastasia·2018·Molecular Therapy
DOI 10.1016/j.ymthe.2018.05.024
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ymthe.2018.05.024

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 47

  1. Grapp, 2013, Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma, Nat. Commun., 4, 2123, 10.1038/ncomms3123 · DOI
  2. Yang, 2015, Exosome delivered anticancer drugs across the blood-brain barrier for brain cancer therapy in Danio rerio, Pharm. Res., 32, 2003, 10.1007/s11095-014-1593-y · DOI
  3. Haraszti, 2016, High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources, J. Extracell. Vesicles, 5, 32570, 10.3402/jev.v5.32570 · DOI · Paper page
  4. Valadi, 2007, Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells, Nat. Cell Biol., 9, 654, 10.1038/ncb1596 · DOI · Paper page
  5. Zomer, 2015, In Vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior, Cell, 161, 1046, 10.1016/j.cell.2015.04.042 · DOI
  6. Xin, 2012, Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth, Stem Cells, 30, 1556, 10.1002/stem.1129 · DOI
  7. Xin, 2013, MiR-133b promotes neural plasticity and functional recovery after treatment of stroke with multipotent mesenchymal stromal cells in rats via transfer of exosome-enriched extracellular particles, Stem Cells, 31, 2737, 10.1002/stem.1409 · DOI
  8. Lee, 2014, Mesenchymal stem cells deliver exogenous miRNAs to neural cells and induce their differentiation and glutamate transporter expression, Stem Cells Dev., 23, 2851, 10.1089/scd.2014.0146 · DOI
  9. Cui, 2016, miR-145 Regulates Diabetes-Bone Marrow Stromal Cell-Induced Neurorestorative Effects in Diabetes Stroke Rats, Stem Cells Transl. Med., 5, 1656, 10.5966/sctm.2015-0349 · DOI
  10. Xin, 2017, Cell Transplant., 26, 243, 10.3727/096368916X693031 · DOI
  11. Zhang, 2017, Exosomes Derived from Mesenchymal Stromal Cells Promote Axonal Growth of Cortical Neurons, Mol. Neurobiol., 54, 2659, 10.1007/s12035-016-9851-0 · DOI
  12. Fire, 1998, Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans, Nature, 391, 806, 10.1038/35888 · DOI · Paper page
  13. Didiot, 2016, Exosome-mediated Delivery of Hydrophobically Modified siRNA for Huntingtin mRNA Silencing, Mol. Ther., 24, 1836, 10.1038/mt.2016.126 · DOI · Paper page
  14. O’Loughlin, 2017, Functional Delivery of Lipid-Conjugated siRNA by Extracellular Vesicles, Mol. Ther., 25, 1580, 10.1016/j.ymthe.2017.03.021 · DOI
  15. Stremersch, 2016, Comparing exosome-like vesicles with liposomes for the functional cellular delivery of small RNAs, J. Control. Release, 232, 51, 10.1016/j.jconrel.2016.04.005 · DOI
  16. Byrne, 2013, Novel hydrophobically modified asymmetric RNAi compounds (sd-rxRNA) demonstrate robust efficacy in the eye, J. Ocul. Pharmacol. Ther., 29, 855, 10.1089/jop.2013.0148 · DOI
  17. Soutschek, 2004, Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs, Nature, 432, 173, 10.1038/nature03121 · DOI
  18. Stremersch, 2017, Nucleic acid loading and fluorescent labeling of isolated extracellular vesicles requires adequate purification, Int. J. Pharm.
  19. Allerson, 2005, Fully 2′-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA, J. Med. Chem., 48, 901, 10.1021/jm049167j · DOI
  20. Choung, 2006, Chemical modification of siRNAs to improve serum stability without loss of efficacy, Biochem. Biophys. Res. Commun., 342, 919, 10.1016/j.bbrc.2006.02.049 · DOI
  21. Czauderna, 2003, Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells, Nucleic Acids Res., 31, 2705, 10.1093/nar/gkg393 · DOI
  22. Coelho, 2013, Safety and efficacy of RNAi therapy for transthyretin amyloidosis, N. Engl. J. Med., 369, 819, 10.1056/NEJMoa1208760 · DOI · Paper page
  23. Hassler, 2018, Comparison of partially and fully chemically-modified siRNA in conjugate-mediated delivery in vivo, Nucleic Acids Res., 46, 2185, 10.1093/nar/gky037 · DOI · Paper page
  24. Prakash, 2016, Synergistic effect of phosphorothioate, 5′-vinylphosphonate and GalNAc modifications for enhancing activity of synthetic siRNA, Bioorg. Med. Chem. Lett., 26, 2817, 10.1016/j.bmcl.2016.04.063 · DOI
  25. Parmar, 2016, 5′-(E)-Vinylphosphonate: A Stable Phosphate Mimic Can Improve the RNAi Activity of siRNA-GalNAc Conjugates, ChemBioChem, 17, 985, 10.1002/cbic.201600130 · DOI
  26. Haraszti, 2017, 5′-Vinylphosphonate improves tissue accumulation and efficacy of conjugated siRNAs in vivo, Nucleic Acids Res., 45, 7581, 10.1093/nar/gkx507 · DOI
  27. Morrissey, 2005, Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs, Nat. Biotechnol., 23, 1002, 10.1038/nbt1122 · DOI
  28. Olearczyk, 2014, Targeting of hepatic angiotensinogen using chemically modified siRNAs results in significant and sustained blood pressure lowering in a rat model of hypertension, Hypertens. Res., 37, 405, 10.1038/hr.2013.155 · DOI
  29. Petrova, 2012, Carrier-free cellular uptake and the gene-silencing activity of the lipophilic siRNAs is strongly affected by the length of the linker between siRNA and lipophilic group, Nucleic Acids Res., 40, 2330, 10.1093/nar/gkr1002 · DOI
  30. Reiner, 2017, Concise Review: Developing Best-Practice Models for the Therapeutic Use of Extracellular Vesicles, Stem Cells Transl. Med., 6, 1730, 10.1002/sctm.17-0055 · DOI
  31. Lener, 2015, Applying extracellular vesicles based therapeutics in clinical trials - an ISEV position paper, J. Extracell. Vesicles, 4, 30087, 10.3402/jev.v4.30087 · DOI · Paper page
  32. Lee, 2016, Exosomes from adipose-derived stem cells ameliorate phenotype of Huntington’s disease in vitro model, Eur. J. Neurosci., 44, 2114, 10.1111/ejn.13275 · DOI · Paper page
  33. Alterman, 2015, Hydrophobically Modified siRNAs Silence Huntingtin mRNA in Primary Neurons and Mouse Brain, Mol. Ther. Nucleic Acids, 4, e266, 10.1038/mtna.2015.38 · DOI · Paper page
  34. Geary, 2015, Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides, Adv. Drug Deliv. Rev., 87, 46, 10.1016/j.addr.2015.01.008 · DOI
  35. Nallagatla, 2008, Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner, RNA, 14, 1201, 10.1261/rna.1007408 · DOI
  36. Jackson, 2006, Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing, RNA, 12, 1197, 10.1261/rna.30706 · DOI
  37. Elkayam, 2017, siRNA carrying an (E)-vinylphosphonate moiety at the 5′ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2, Nucleic Acids Res., 45, 3528, 10.1093/nar/gkw1171 · DOI
  38. Dovydenko, 2016, Method of carrier-free delivery of therapeutic RNA importable into human mitochondria: Lipophilic conjugates with cleavable bonds, Biomaterials, 76, 408, 10.1016/j.biomaterials.2015.10.075 · DOI
  39. Chen, 2010, Lipophilic siRNAs mediate efficient gene silencing in oligodendrocytes with direct CNS delivery, J. Control. Release, 144, 227, 10.1016/j.jconrel.2010.02.011 · DOI
  40. Pi, 2018, Nanoparticle orientation to control RNA loading and ligand display on extracellular vesicles for cancer regression, Nat. Nanotechnol., 13, 82, 10.1038/s41565-017-0012-z · DOI
  41. Keerthikumar, 2016, ExoCarta: A Web-Based Compendium of Exosomal Cargo, J. Mol. Biol., 428, 688, 10.1016/j.jmb.2015.09.019 · DOI
  42. Heusermann, 2016, Exosomes surf on filopodia to enter cells at endocytic hot spots, traffic within endosomes, and are targeted to the ER, J. Cell Biol., 213, 173, 10.1083/jcb.201506084 · DOI · Paper page
  43. Montecalvo, 2012, Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes, Blood, 119, 756, 10.1182/blood-2011-02-338004 · DOI · Paper page
  44. Yuyama, 2012, Sphingolipid-modulated exosome secretion promotes clearance of amyloid-β by microglia, J. Biol. Chem., 287, 10977, 10.1074/jbc.M111.324616 · DOI
  45. Sagar, 2016, Pathogenesis of pancreatic cancer exosome-induced lipolysis in adipose tissue, Gut, 65, 1165, 10.1136/gutjnl-2014-308350 · DOI
  46. Griffiths, 2017, Differential Proteome Analysis of Extracellular Vesicles from Breast Cancer Cell Lines by Chaperone Affinity Enrichment, Proteomes, 5, E25, 10.3390/proteomes5040025 · DOI
  47. Coles, 2016, A High-Throughput Method for Direct Detection of Therapeutic Oligonucleotide-Induced Gene Silencing In Vivo, Nucleic Acid Ther., 26, 86, 10.1089/nat.2015.0578 · DOI

Cited by

Sorted by citations

See all 107

Metadata

Authors
Haraszti, R. A., Miller, R., Didiot, M.-C., Biscans, A., Alterman, J. F., Hassler, M. R., Roux, L., Echeverria, D., Sapp, E., DiFiglia, M., Aronin, N., & Khvorova, A.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2018-08
Volume
26
Issue
8
Pages
1973-1982
ISSN
1525-0016
DOI
10.1016/j.ymthe.2018.05.024
Cited by
107
References
8
Language
en
Licence
Funders
  • NIH (TR 000888 05, RO1GM10880304, RO1NS10402201, S10 OD020012)
  • UMass (CCTS UL1 TR000161)
  • CHDI Foundation (A-6119, JSC A6367)
  • Huntington’s Disease Society of America

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles. https://app.cochat.ai/papers/10.1016/j.ymthe.2018.05.024
The paper
Haraszti, R. A., Miller, R., Didiot, M.-C., Biscans, A., Alterman, J. F., Hassler, M. R., Roux, L., Echeverria, D., Sapp, E., DiFiglia, M., Aronin, N., & Khvorova, A. (2018). Optimized Cholesterol-siRNA Chemistry Improves Productive Loading onto Extracellular Vesicles. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2018.05.024